/

Società

Br

Non verificato

Brenus Pharma

Di cosa scriviamo

BiotecnologiaFarmaceuticaOncologiaSaluteScienza

15 comunicati stampa

Guarda tutti i comunicati

20/07/2026

Scienza

Medicina - Varie

Biotecnologia

Salute

Farmaceutica

Oncologia

Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension

Fonte

Emittente

1.00

0

02/07/2026

Mercato del lavoro

Oncologia

Salute

Medicina - Varie

Scienza

Farmaceutica

Biotecnologia

Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member

Fonte

Emittente

1.00

0

27/05/2026

Scienza

Igiene alimentare

Medicina - Varie

Sanità

Biotecnologia

Farmaceutica

Salute

Oncologia

Industria

Eventi

Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)

Fonte

Emittente

1.00

0

14/04/2026

Eventi

Fiere

Industria

Oncologia

Salute

Medicina - Varie

Scienza

Farmaceutica

Biotecnologia

AACR 2026: First‑in‑Human STC‑1010 Data Show Favorable Safety and Early Immune Engagement in Metastatic MSS Colorectal Cancer

Fonte

Emittente

1.00

0

19/02/2026

Scienza

Biotecnologia

Farmaceutica

Oncologia

Salute

Eventi

Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026

Fonte

Emittente

1.00

0

06/01/2026

Industria

Scienza

Medicina - Varie

Biotecnologia

Salute

Farmaceutica

Sanità

Oncologia

Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients

Fonte

Emittente

1.00

0

12/11/2025

Oncologia

Salute

Scienza

Sanità

Biotecnologia

Eventi

Mercato del lavoro

Industria

Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn

Fonte

Emittente

1.00

0

02/09/2025

Industria

Scienza

Biotecnologia

Farmaceutica

Oncologia

Sanità

Salute

Medicina - Varie

Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy

Fonte

Emittente

1.00

0

19/06/2025

Scienza

Biotecnologia

Oncologia

Salute

Attrezzature medico-sanitarie

Sanità

Industria

Eventi

Brenus Pharma and InSphero Have Developed 3D Tumor Spheroids Mimicking in vivo Human Colorectal Cancer Conditions and Confirming STC-1010’s Efficacy

Fonte

Emittente

1.00

0

07/05/2025

AACR 2025: Brenus Pharma Presents Late-breaking Preclinical Data on its “off-the-shelf” Next-generation Vaccine-based Immunotherapy Candidate, STC-1010, Now Moving to Clinic

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0